Cargando…
Co-expression of active human cytochrome P450 1A2 and cytochrome P450 reductase on the cell surface of Escherichia coli
BACKGROUND: Human cytochrome P450 (CYP) enzymes mediate the first step in the breakdown of most drugs and are strongly involved in drug–drug interactions, drug clearance and activation of prodrugs. Their biocatalytic behavior is a key parameter during drug development which requires preparative synt...
Autores principales: | Quehl, Paul, Hollender, Joel, Schüürmann, Jan, Brossette, Tatjana, Maas, Ruth, Jose, Joachim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4736170/ https://www.ncbi.nlm.nih.gov/pubmed/26838175 http://dx.doi.org/10.1186/s12934-016-0427-5 |
Ejemplares similares
-
The FMN “140s Loop” of Cytochrome P450 Reductase Controls Electron Transfer to Cytochrome P450
por: Rwere, Freeborn, et al.
Publicado: (2021) -
Allosteric modulation of cytochrome P450 enzymes by the NADPH cytochrome P450 reductase FMN-containing domain
por: Burris-Hiday, Sarah D., et al.
Publicado: (2023) -
Conformational Landscape of Cytochrome P450 Reductase Interactions
por: Sellner, Manuel, et al.
Publicado: (2021) -
Orchestrated Domain Movement in Catalysis by Cytochrome P450 Reductase
por: Freeman, Samuel L., et al.
Publicado: (2017) -
Cytochrome P450 reductase (POR) as a ferroptosis fuel
por: Koppula, Pranavi, et al.
Publicado: (2021)